These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7341025)

  • 21. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis.
    Burgess ED; Gill MJ
    J Clin Pharmacol; 1990 Nov; 30(11):997-1000. PubMed ID: 2243158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications.
    Hodler JE; Galeazzi RL; Frey B; Rudhardt M; Seiler AJ
    Eur J Clin Pharmacol; 1984; 26(5):609-12. PubMed ID: 6468477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.
    Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN
    J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of congestive heart failure on quinidine pharmacokinetics.
    Crouthamel WG
    Am Heart J; 1975 Sep; 90(3):335-9. PubMed ID: 1163425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphate clearance in peritoneal dialysis: automated PD compared with continuous ambulatory PD.
    Sawin DA; Himmele R; Diaz-Buxo JA
    Adv Perit Dial; 2012; 28():120-5. PubMed ID: 23311227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketoconazole kinetics in chronic peritoneal dialysis.
    Johnson RJ; Blair AD; Ahmad S
    Clin Pharmacol Ther; 1985 Mar; 37(3):325-9. PubMed ID: 3971656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of digoxin in C.A.P.D.
    De Paepe M; Belpaire F; Bogaerts Y
    Clin Exp Dial Apheresis; 1982; 6(1):65-73. PubMed ID: 7094416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.
    Guay DR; Meatherall RC; Baxter H; Jacyk WR; Penner B
    Antimicrob Agents Chemother; 1984 Mar; 25(3):306-10. PubMed ID: 6721462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic studies of quinidine in patients with arrhythmias.
    Conrad KA; Molk BL; Chidsey CA
    Circulation; 1977 Jan; 55(1):1-7. PubMed ID: 830196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.
    Rogge MC; Johnson CA; Zimmerman SW; Welling PG
    Antimicrob Agents Chemother; 1985 Apr; 27(4):578-82. PubMed ID: 4004194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Sica DA; Comstock T; Harford A; Eshelman F
    Eur J Clin Pharmacol; 1987; 32(6):587-91. PubMed ID: 3653228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
    Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
    Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.